These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17875901)

  • 1. Lymphomatoid granulomatosis induced by imatinib-treatment.
    Yazdi AS; Metzler G; Weyrauch S; Berneburg M; Bitzer M; Müller-Hermelink HK; Röcken M
    Arch Dermatol; 2007 Sep; 143(9):1222-3. PubMed ID: 17875901
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphomatoid granulomatosis in a patient previously diagnosed with a gastrointestinal stromal tumour and treated with imatinib.
    Salmons N; Gregg RJ; Pallalau A; Woolhouse I; Geh I; Tanière P
    J Clin Pathol; 2007 Feb; 60(2):199-201. PubMed ID: 17264244
    [No Abstract]   [Full Text] [Related]  

  • 3. Imatinib mesylate induced skin hypopigmentation.
    Talwar V; Doval DC; Bhatia K
    J Assoc Physicians India; 2007 Jul; 55():527. PubMed ID: 17907508
    [No Abstract]   [Full Text] [Related]  

  • 4. Halo nevi related to treatment with imatinib in a dermatofibrosarcoma protuberans patient.
    Fava P; Stroppiana E; Savoia P; Bernengo MG
    J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):244-5. PubMed ID: 19694892
    [No Abstract]   [Full Text] [Related]  

  • 5. Catastrophic tumour lysis syndrome following single dose of imatinib.
    Keane C; Henden A; Bird R
    Eur J Haematol; 2009 Mar; 82(3):244-5. PubMed ID: 19067739
    [No Abstract]   [Full Text] [Related]  

  • 6. Imatinib-associated hyperpigmentation, a side effect that should be recognized.
    Mcpherson T; Sherman V; Turner R
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):82-3. PubMed ID: 18384557
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphomatoid granulomatosis presenting as polyarthritis.
    Bergin C; Stein HB; Boyko W; Hogg J; Schlappner O
    J Rheumatol; 1984 Aug; 11(4):537-9. PubMed ID: 6481727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Episodic angioedema with eosinophilia: successful treatment with imatinib.
    Scranton SE; Wild CA; England RW
    Ann Allergy Asthma Immunol; 2008 Feb; 100(2):172-4. PubMed ID: 18320923
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe hemolytic anemia and skin reaction in a patient treated with imatinib.
    De Arriba JJ; Nerín C; García E; Gómez-Aldaraví L; Vila B
    Ann Oncol; 2003 Jun; 14(6):962. PubMed ID: 12796039
    [No Abstract]   [Full Text] [Related]  

  • 10. [A variety of lymphomatoid granulomatosis, pseudosarcoid granulomatosis. An anatomo-clinical observation with an ultrastructural study].
    Chomette G; Auriol M; Deboise A; Bertrand JC; Vaillant JM
    Rev Stomatol Chir Maxillofac; 1983; 84(3):157-61. PubMed ID: 6575437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lymphomatoid granulomatosis: a clinical case].
    Lavados M; Feuerhake W; Pruyas M; Vergara F
    Rev Med Chil; 1990 May; 118(5):555-61. PubMed ID: 2293276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia.
    Khan KA; Junaid A; Siddiqui NS; Mukhtar K; Siddiqui S
    J Coll Physicians Surg Pak; 2008 Mar; 18(3):176-8. PubMed ID: 18460249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Gleevec treatment approved.
    FDA Consum; 2002; 36(2):6. PubMed ID: 11989477
    [No Abstract]   [Full Text] [Related]  

  • 14. [Imatinib and solid tumours].
    Arifi S; El Sayadi H; Dufresne A; Ray-Coquard I; Fayette J; Méeus P; Ranchère D; Decouvelaere AV; Alberti L; Tabone-Eglinger S; Blay JY; Cassier P
    Bull Cancer; 2008 Jan; 95(1):99-106. PubMed ID: 18230575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular side effects in chronic myeloid leukemia patients treated with imatinib.
    Breccia M; Gentilini F; Cannella L; Latagliata R; Carmosino I; Frustaci A; Alimena G
    Leuk Res; 2008 Jul; 32(7):1022-5. PubMed ID: 18061664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Imatinib-induced DRESS].
    Goldman J; Duval-Modeste AB; Lambert A; Contentin N; Courville P; Musette P; Joly P
    Ann Dermatol Venereol; 2008 May; 135(5):393-6. PubMed ID: 18457727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of imatinib in unresectable hepatocellular carcinoma.
    Lin AY; Fisher GA; So S; Tang C; Levitt L
    Am J Clin Oncol; 2008 Feb; 31(1):84-8. PubMed ID: 18376233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.
    Cohen MH; Farrell A; Justice R; Pazdur R
    Oncologist; 2009 Feb; 14(2):174-80. PubMed ID: 19193781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor.
    Santachiara R; Maffei R; Martinelli S; Arcari A; Piacentini F; Trabacchi E; Alfieri P; Ferrari A; Leonardi G; Luppi G; Longo G; Vallisa D; Marasca R; Torelli G
    Haematologica; 2008 Aug; 93(8):1252-5. PubMed ID: 18519520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratoacanthomas associated with imatinib mesylate.
    Balagula Y; Busam KJ; Carvajal RD; Wolchok JD; Myskowski PL
    Acta Oncol; 2011 May; 50(4):593-5. PubMed ID: 21108567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.